The purpose of this study was to examine plasma cholinesterase (PChE) changes and the adverse health effects associated with chronic low-dose exposure to organophosphates (OPs) in a Peruvian agricultural population. A cross-sectional study with a clinical interview and blood tests was performed among 213 farm workers from two subtropical valleys in Peru. The control group consisted of 78 nonexposed workers from the same areas. PChE levels from the two exposed subgroups (pesticide applicators and other agricultural jobs) were significantly lower than those of controls (1554 +/- 315 U/l, 1532 +/- 340 U/l, and 1787 +/- 275 U/l, respectively). Fifteen percent of the exposed population reported a past poisoning by pesticides, all of them needing medical evaluation and treatment. They had significantly lower PChE levels as compared to those without this antecedent. Approximately 61% of the exposed workers reported pesticide-related symptoms, but no significant difference was found in their PChE as compared to workers without symptoms. On the other hand, the use of personal protective equipment (PPE) was significantly associated with higher PChE levels and with a lower risk of reporting pesticide-related symptoms, which supports the benefit from using appropriate protective measures. In conclusion, data indicate that farm workers exposed to OPs in developing countries need to be monitored by means of PChE and an examination of their clinical status, which would allow identification of farm workers most at risk from pesticide toxicity. The use of correct PPE is highly recommended.

Paraoxonase-1 (PON1) is a serum esterase associated with high density lipoproteins and capable of detoxifying toxic metabolites of organophosphorus (OP) compounds. Two major polymorphisms have been described in the coding region of the PON1 gene at positions 192 and 55 and at least five in the 5 0 -regulatory region, the most important at position À108. Depending on the substrate, PON1 192 Q/R polymorphism can affect PON1 enzymatic activity. In the present study, we have determined the distribution of the PON1 192 Q/R and À108 C/T polymorphisms in a Peruvian population and compared the distribution of these polymorphisms with those of other world populations. PON1 phenotype and enzyme activity also were measured as they can influence the population resistance to the toxicity of OP compounds. The genotype distribution at position 192 was: QQ ¼ 0.236, QR ¼ 0.607, and RR ¼ 0.157; and distribution at position À108 was: CC ¼ 0.315, CT ¼ 0.596, and TT ¼ 0.089. The frequencies of the high activity R and C alleles were 0.461 and 0.613, respectively. The frequency of the PON1 192 Q allele was significantly lower than that of American, Caucasian-American, European-Brazilian, and Costa Rican samples. Outside the American continent, the frequency of this allele was lower than for all European countries, Thais, and Indians, but higher than for Chinese or Japanese. Regarding the toxicological importance of these polymorphisms, it was inferred that PON1 phenotyping (assessment of the R alloform) and genotyping (determination of the PON1 -108TT genotype) could be helpful as individual markers of susceptibility. PON1 phenotyping may be useful in further epidemiological studies involving agriculture workers occupationally exposed to OP compounds in developing countries. Environ. Mol. Mutagen. 47:699-706, 2006. V V C 2006 Wiley-Liss, Inc.

We investigated the time course and the reproducibility of the relative-dose-response (RDR) test for assessing vitamin A status in older adults. The maximum plasma retinol response to 480 retinol equivalents (RE) of retinyl palmitate in abnormal responses was at 6 or 7 h after dosing compared with the 5-h sampling interval recommended by others for younger adults and children. With respect to reproducibility, the diagnostic concordance of two RDR tests at 7-d intervals in 14 elders was 71%. In 29% of tests, one test was abnormal and the other normal. Linear regression of the two RDR values in these 14 subjects gave a correlation coefficient of -0.08. We conclude that the procedure for the RDR should be modified when applied to persons greater than 60 y of age, and that multiple repetitions of the test are needed to provide a stable indication of vitamin A stores in an elderly individual.

No abstract

No abstract